Pfizer Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pfizer Inc. with three other
companies in this sector in the United States:
sales of $38.31 billion
of which 84%
Merck & Co. , Inc.
of which 88%
was Merck Pharmaceutical), and
of which 66%
was innovative medicines).
During the year ended December of 2016, sales at
Pfizer Inc. were $52.82 billion.
increase of 8.1%
versus 2015, when the company's sales were $48.85 billion.